alexa
Reach Us +44-1647-403003
Drug Repurposing for Cancer Therapy | OMICS International | Abstract
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Editorial

Drug Repurposing for Cancer Therapy

Carlos M. Telleria*

Division of Basic Biomedical Sciences, Sanford School of Medicine of The University of South Dakota, 414 East Clark Street, Vermillion, SD 57069, USA

*Corresponding Author:
Carlos M. Telleria
Division of Basic Biomedical Sciences
Sanford School of Medicine of The University of South Dakota
414 East Clark Street, Vermillion, SD 57069, USA
E-mail: [email protected]

Received Date: July 19, 2012; Accepted Date: July 21, 2012; Published Date: July 21, 2012

Citation: Telleria CM (2012) Drug Repurposing for Cancer Therapy. J Cancer Sci Ther 4: ix-xi. doi: 10.4172/1948-5956.1000e108>

Copyright: © 2012 Telleria CM. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Clinicians should develop new hypotheses based on observations and interviews with patients, and basic researchers should go back to the bench to test compounds with anticipated anti-growth properties. Let’s not forget that the most popularly used anticancer agent, platinum, was discovered serendipitously when microbiologists were investigating the behavior of bacteria upon changes in voltage and observed growth inhibition due to electrolysis products from a platinum electrode. Hopefully, using all these resources, we will convert cancer into a treatable chronic disease. The current technological armamentarium provides cancer researchers with a unique opportunity to find new targets for old synthetic, abandoned compounds or newly discovered natural products.

Keywords

Recommended Conferences
Share This Page
Top